Last reviewed · How we verify
CXB909
At a glance
| Generic name | CXB909 |
|---|---|
| Sponsor | CeNeRx BioPharma Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic Study of CXB909 in Healthy Male Subjects (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CXB909 CI brief — competitive landscape report
- CXB909 updates RSS · CI watch RSS
- CeNeRx BioPharma Inc. portfolio CI